Psychedelics Archives - Page 2 of 8 - Reason Foundation

Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — February 2025

Commentary by Gregory Ferenstein

DEA’s increased DMT quota signals positive advancement in psychedelic research

Commentary by Madison Carlino

Rethinking the need for double-blind placebo trials in psychedelic clinical investigations

Commentary by Madison Carlino

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic therapy offers possible new hope for Alzheimer’s disease sufferers

Commentary by Madison Carlino

Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — December 2024

Commentary by Gregory Ferenstein

Psychedelic drug policy recommendations for the incoming Trump administration

Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

More Psychedelics

Prev
1
2
3
4
5
6
7
...
8
Next